Barge OJ, Ramsfjell V, Veiby OP, et al. Thrombopoietin, but not erythropoietin promotes viability and inhibits apoptosis of multipotent murinehematopoietic progenitor cells in vitro[J]. Blood, 1996, 88(8): 2859-2870.
Kuter DJ, Begley CG. Recombinant human thrombopoietin: basic biology and evaluation of clinical studies[J]. Blood, 2002, 100(10): 3457-3469.
[4]
Vadhan-Raj S, Verschraegen CF, Bueso-Ramos C, et al. Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer[J]. Ann Intern Med, 2000, 132(5): 364-368.
[5]
Vadhan-Raj S. Recombinant human thrombopoietin in myelosuppressive chemotherapy[J]. Oncology, 2001, 15(7, Suppl 8): 35-38.
